Around 1% of the world’s population lives with epilepsy; yet only 65% of epilepsy patients can manage their symptoms with medication. Currently, surgically removing the lesion in the brain responsible for the condition is the only radical cure for epilepsy. Still, many patients have to take medication for the rest of their life to deal with their seizures.

A research group led by professor Ko Matsui from the Super-network Brain Physiology Lab at Tohoku University reported on a stimulation paradigm used on experimental animals that could potentially cultivate resilience to epilepsy.

Frequent seizure-evoking stimulation to the brain has been shown to induce epileptogenesis and epileptic brain conditions. To the researcher’s surprise, however, repeated stimulation resulted in a dramatic decrease in the seizure response to the stimulus.

“Our brain has an infinite ability for plasticity,” says Matsui. “If an epileptic state can be created, we must query whether it is also conceivable to reverse the transition or to override the existing hyper-excitable circuit with an additional suppressive system.”

Using optogenetics technology to control the activity, Dr. Yoshiteru Shimoda, Matsui and their team demonstrated that a specific stimulation paradigm prompted the release of the endogenous inhibitory transmitter adenosine from glial cells. This converted the rat’s brain to a state strongly resistant to seizures.

Details of their findings were published in Neurobiology of Disease online.

Matsui is cautiously optimistic. “Although epileptogenesis unfortunately could not be reversed, we showed we could invoke the homeostatic nature of the brain circuit to contain hyper-excitation.”

For the current study, light-sensitive proteins were genetically expressed in neurons to regulate moderate neuron-to-glial signaling at will. Such optogenetic technology would be difficult to apply in human patients, noted Matsui.

“Despite clinical use being a long way off, it is possible to imagine a future where a therapeutic strategy can directly target glial cells and enable the creation of an epileptic resistant state.”



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

Study highlights complexity of menopausal hormone therapy’s impact on brain health

A study suggests that menopausal hormone therapy (MHT) might have moderate effects on brain health, but this depends on past surgical history, the duration of treatment, and a woman’s age

A hidden Alzheimer’s tipping point may decide who gets dementia

Researchers from VIB, KU Leuven, the UK-DRI and Muna Therapeutics, with funding that included support from ERC, have identified a major biological shift that may help determine whether Alzheimer’s disease

Evidence of potential bed bug insecticide resistance in gene mutation

A global infestation of bed bugs after World War II was nearly eradicated in the 1950s with the use of the pesticide dichloro-diphenyl-trichloroethane, commonly known as DDT, a chemical that